| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |